Ignite Creation Date:
2024-05-06 @ 3:24 AM
Last Modification Date:
2024-10-26 @ 11:33 AM
Study NCT ID:
NCT02281318
Status:
COMPLETED
Last Update Posted:
2018-08-06
First Post:
2014-10-30
Brief Title:
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-11
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-10
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-30
First Submit QC Date:
October 30 2014
Study First Post Date:
2014-11-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2017-05-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-02
Last Update Post Date:
2018-08-06
Last Update Post Date Type:
ACTUAL